,,iv  #aai? ,,congress  #b;d ,session   
,h4 ,,res4 #afja  ,,9 ,,! ,,h\se ,,(    
,,repres5tatives  ,octob] #a1 #bjbf,mr4 
,mill] ( ,ohio 7= himself1 ,mr4 ,kelly (
 ,p5nsylvania1 & ,mrs4 ,cammack7        
submitt$ ! foll[+ resolution2 :i* 0     
ref]r$ to ! ,committee on ,en]gy &      
,comm]ce  ,,resolution  ,recogniz+      
,septemb] z ,*ildhood ,canc] ,aw>5ess   
,mon?4  ,:]eas ,septemb] is recogniz$ z 
,*ildhood ,canc] ,aw>5ess ,mon?1 & !    
annual obs]vance br+s att5tion to *ildr5
 & families affect$ by canc] & !        
importance ( advancem5ts to improve     
survival rates & quality ( life =       
p$iatric canc] pati5ts2 ,:]eas *ildhood 
canc] rema9s ! lead+ cause ( dea? by    
disease among *ildr5 pa/ infancy 9 !    
,unit$ ,/ates2 ,:]eas1 due to m$ical    
advancem5ts1 scre5+1 & aw>5ess1 #hf     
p]c5t ( *ildr5 ) canc] n[ survive #e    
ye>s or m1 :i* is a significant         
advancem5t s9ce ! mid-#aigjs :5 !       
survival rate 0 only #eh p]c5t2 h[ev]1  
too _m "y lives are /ill lo/ or         

jeop>diz$2 ,:]eas *ildhood canc]s c     
diff] f adult canc]s1 ) unique          
biological *>act]i/ics & treatm5t dep5d+
 on ! type ( canc] & ! *ild's           
circum/ances1 & ) survivors (t5 impact$ 
by ! long-t]m effects ( canc]2 ,:]eas   
*ildhood canc] includes sev]al diff]5t  
diseases &1 accord+ to ! ,national      
,canc] ,in/itute's *ildhood canc]       
ov]view1 leukemias1 bra9 & o!r c5tral   
n]v\s sy/em tumors1 & lymphomas are     
among ! mo/ common canc]s 9 *ildr5 up to
 age #ad2 ,:]eas ! impacts ( canc] & its
 treatm5t 9 *ildhood1 adolesc5ce1 or "y 
adul?ood may affect heal? ye>s lat]1 )  
#if p]c5t ( *ildhood canc] survivors    
develop+ "o or m *ronic heal? conditions
 & ov] #bj p]c5t ( su* survivors        
exp]i5c+ sev]e or life-?reat5+          
complications into adul?ood2 ,:]eas !   
d$icat$ commitm5t ( individuals treat+ &
 advanc+ rese>* to address *ildhood     
canc] is pivotal2 ,:]eas treatm5t me?ods
 = *ildhood canc]s cont9ue to evolve z m
 advanc$ treatm5ts are develop$ to      

improve survival rates & quality ( life 
= p$iatric canc] pati5ts ?r\gh drug     
discov]y & cl9ical trials1 accel]at+    
saf] & m effective treatm5ts = *ildr5 ) 
canc] & bett] utilization ( valuable    
heal? c>e res\rces2 ,:]eas ! presid5tial
 message on ,national ,*ildhood ,canc]  
,aw>5ess ,mon? call$ = br++ toge!r      
,am]ican innovation & cutt+-edge        
te*nology1 provid+ new hope to *ildr5 & 
families fight+ canc]2 & ,:]eas1 :ile   
*ildhood canc]s are ! lead+ cause ( dea?
 f disease among *ildr5 9 ! ,unit$      
,/ates1 ov] ! pa/ sev]al decades !      
#e-ye> survival rate = *ildhood canc]   
has improv$1 b despite ^? advances1     
approximately #a1hbj *ildr5 & adolesc5ts
 9 ! ,unit$ ,/ates die ( canc] ea* ye>3 
,n[1 !re=e1 be x  ,t ! ,h\se (          
,repres5tatives-- 7#a7 expresses support
 = ! recognition ( ,*ildhood ,canc]     
,aw>5ess ,mon?2  7#b7 affirms a r5ew$   
national commitm5t to address *ildhood  
canc] 9 ! ,unit$ ,/ates by advanc+      
innovation to accel]ate ! developm5t (  

saf] & m effective treatm5ts to improve 
survival rates & quality ( life =       
p$iatric canc] pati5ts2 &  7#c7 comm5ds 
! d$icat$ commitm5t ( individuals :o    
provide treatm5t & c>e = *ildr5 & _!    
families impact$ by canc]1 & recognizes 
! trans=mative role ( su* individuals 9 
r$uc+ ! burd5 ( canc]1 !reby improv+    
long-t]m heal? outcomes = *ildr5 9 !    
,unit$ ,/ates & mak+ a positive impact  
on _! futures4